Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Realy Tech is a China-based in vitro diagnostics company focused on point-of-care testing, rapid tests, immunoassay systems, and related analytical medical devices. The company manufactures rapid diagnostic kits, portable and quantitative immunoassay analyzers, automatic chemiluminescence immunoassay systems, PCR assays, and drugs-of-abuse testing products. Its menu spans infectious disease, cardiovascular, hepatitis, diabetes, women's health, and tumor marker applications, with company materials stating compatibility with nearly 150 immune markers. Realy Tech appears to operate as a commercial-stage diagnostics manufacturer rather than a therapeutics developer, with products marketed internationally and OEM services offered to partners and distributors. The company emphasizes in-house R&D, ISO 13485-certified manufacturing, and NMPA-inspected production facilities in Hangzhou.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Realy Tech.